Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.160
+0.350 (9.19%)
Sep 16, 2025, 1:25 PM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $44.93 million as of September 16, 2025. Its market cap has increased by 0.32% in one year.
Market Cap
44.93M
Enterprise Value
25.39M
1-Year Change
0.32%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $44.93M, an increase of 48.13%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 41.15M | 19.60% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |